Dr. Brett King is Assistant Professor of Dermatology, specializing in skin diseases recalcitrant to first-line therapies. He also conducts clinical trials to try to identify new treatments for skin disorders. He sees patients at Yale Dermatology-Middlebury and the West Haven VA.
He is experienced with the use of systemic medications including retinoids, methotrexate, cyclosporine, azathioprine (Imuran®), mycophenolate mofetil (Cellcept®), tofacitinib (Xeljanz®), ruxolitinib (Jakafi®), and the ‘biologics’(e.g. etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®), ustekinumab (Stelara®), secukinumab (Cosenytx®), and ixekizumab (Taltz®)) as well as phototherapy.
Dr. King received his B.A. at the University of California at Santa Cruz, his Ph.D. from Stanford University and his M.D. from Yale University School of Medicine. He completed medicine internship at Massachusetts General Hospital and dermatology residency at Yale University School of Medicine.
Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From physicians only
Patient Care Organizations
Dermatology AB of Dermatology (2009)
|Diseases of the Integumentary System||Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata|
|Diseases of the Integumentary System, Diseases of the Musculoskeletal System||Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants|